Our strategic R&D centres
Our R&D centres
We are committed to our purpose of pushing the boundaries of science to deliver life changing medicines and we have built our business around it. We have an active R&D presence in more than 60 countries across the globe with strategic R&D centres including The Discovery Centre (DISC) in Cambridge, UK, with other centres in Gaithersburg, Maryland in the greater Washington, D.C. region in the US, and Gothenburg in Sweden, together with the recently announced centre to be located in Kendall Square in Boston, MA, and the acquisition of Alexion added a Rare Disease R&D Centre of Excellence in New Haven, Connecticut, US.